Krystal Biotech Inc Earnings

The next earnings date for Krystal Biotech Inc is August 4, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Krystal Biotech Inc Earnings

Report DateEstimated Earnings Per Share
11/10/2025$1.35
08/04/2025$1.22

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Krystal Biotech Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/05/2025Before Market$1.2016.14%
02/24/2025Before Market$1.53-17.39%
11/04/2024Before Market$0.911.11%
08/05/2024Before Market$0.53-8.62%
05/06/2024Before Market$0.03-80.00%
02/26/2024Before Market$0.30178.95%
11/06/2023Before Market$-0.69-137.93%
08/07/2023Before Market$-1.25-68.92%
05/08/2023Before Market$-1.76-22.22%
02/27/2023Before Market$-1.255.30%
11/07/2022Before Market$-1.174.10%
08/08/2022Before Market$-1.10-7.84%
05/09/2022After Market$-0.995.71%
02/28/2022Before Market$-0.95-30.14%
11/08/2021Before Market$-0.705.41%
08/09/2021Before Market$-0.742.63%
05/10/2021Before Market$-0.67-19.64%
03/01/2021Before Market$-0.5310.17%
11/09/2020Before Market$-0.49-4.26%
08/10/2020Before Market$-0.3721.28%
05/04/2020Before Market$-0.3129.55%
03/10/2020Before Market$-0.316.06%
11/04/2019Before Market$-0.2535.90%
08/05/2019Before Market$-0.37-15.63%
05/06/2019Before Market$-0.2912.12%
03/12/2019Before Market$-0.27-17.39%
11/05/2018Before Market$-0.260.00%
08/06/2018Before Market$-0.2235.29%
05/07/2018Before Market$-0.2156.25%
03/12/2018Before Market$-0.26-13.04%
11/13/2017After Market$-1.26-70.27%
09/20/2017After Market$-0.06---

More About Krystal Biotech Inc

Website
https://www.krystalbio.com
Country
USA
Full Time Employees
275

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

“Krystal Biotech Inc Earnings” Can Refer to the Krystal Biotech Inc Earnings Date

Some people say “Krystal Biotech Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Krystal Biotech Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Krystal Biotech Inc Stock on the Earnings Date

If you own Krystal Biotech Inc stock (KRYS) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Krystal Biotech Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Krystal Biotech Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Krystal Biotech Inc Earnings

You can contact us any time if you would like to ask questions about Krystal Biotech Inc earnings or anything else related to the stock market.